Rice Partnership’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.24M Buy
+2,960
New +$2.24M 0.26% 57

Other funds holding REGN

Rice Partnership's REGN Position: Q3 2026 in Review

Rice Partnership opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 2,960 shares worth $2.24M. The stake represents 0.26% of the portfolio and ranks #57 among its holdings.

1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Rice Partnership held 2,960 shares of Regeneron Pharmaceuticals worth $2.24M as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Rice Partnership position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.26% of Rice Partnership's portfolio in Q3 2026, its #57 holding.
  • 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Rice Partnership's 13F filing for Q3 2026, filed 9 Nov 2026.